Literature DB >> 29266364

Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives.

Neil Bailard1, Elizabeth Rebello1.   

Abstract

Keywords:  aprepitant; contraceptives; drug interactions; medication safety; patient safety; pharmacodynamics; pregnancy

Mesh：

Substances：

Year:  2017        PMID： 29266364      PMCID： PMC5809356          DOI： 10.1111/bcp.13472

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  5 in total

1.  Sugammadex - time of onset: nine months.

Authors:  J Dalton; G Van Hasselt
Journal:  Anaesthesia       Date:  2016-01       Impact factor: 6.955

Review 2.  Aprepitant and fosaprepitant drug interactions: a systematic review.

Authors:  Priya Patel; J Steven Leeder; Micheline Piquette-Miller; L Lee Dupuis
Journal:  Br J Clin Pharmacol       Date:  2017-06-10       Impact factor: 4.335

Review 3.  Aprepitant: drug-drug interactions in perspective.

Authors:  M S Aapro; C M Walko
Journal:  Ann Oncol       Date:  2010-05-20       Impact factor: 32.976

4.  THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein-coupled receptors.

Authors:  Stephen Ph Alexander; Arthur Christopoulos; Anthony P Davenport; Eamonn Kelly; Neil V Marrion; John A Peters; Elena Faccenda; Simon D Harding; Adam J Pawson; Joanna L Sharman; Christopher Southan; Jamie A Davies
Journal:  Br J Pharmacol       Date:  2017-12       Impact factor: 8.739

5.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands.

Authors:  Christopher Southan; Joanna L Sharman; Helen E Benson; Elena Faccenda; Adam J Pawson; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Michael Spedding; William A Catterall; Doriano Fabbro; Jamie A Davies
Journal:  Nucleic Acids Res       Date:  2015-10-12       Impact factor: 16.971
  5 in total
  3 in total

1.  Response to 'Aprepitant and fosaprepitant decrease the effectiveness of hormonal contraceptives'.

Authors:  Priya Patel; J Steven Leeder; Micheline Piquette-Miller; L Lee Dupuis
Journal:  Br J Clin Pharmacol       Date:  2018-01-06       Impact factor: 4.335

Review 2.  [Update on PONV-What is new in prophylaxis and treatment of postoperative nausea and vomiting? : Summary of recent consensus recommendations and Cochrane reviews on prophylaxis and treatment of postoperative nausea and vomiting].

Authors:  Peter Kienbaum; Maximilian S Schaefer; Stephanie Weibel; Tobias Schlesinger; Patrick Meybohm; Leopold H Eberhart; Peter Kranke
Journal:  Anaesthesist       Date:  2021-10-01       Impact factor: 1.041

3.  Perioperative Administration of Emend® (Aprepitant) at a Tertiary Care Children's Hospital: A 12-Month Survey.

Authors:  Anuradha Kanaparthi; Sarah Kukura; Natalie Slenkovich; Faris AlGhamdi; Shabana Z Shafy; Mohammed Hakim; Joseph D Tobias
Journal:  Clin Pharmacol       Date:  2019-11-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.